Zum Inhalt
EB2027 | Vienna | 4-6 November 2026

 

EB2027

SAVE THE DATE
4–6 November 2027 | Vienna, Austria

The EB2027 International Congress is Coming to Vienna!


From 4 to 6 November 2027, Vienna, Austria, will host a leading international congress dedicated to Epidermolysis Bullosa (EB), bringing together expertise in research, clinical care, patient leadership and infrastructure to strengthen collaboration and translate shared ideas into concrete actions.


The global EB community has reached a pivotal moment. Scientific breakthroughs, novel therapies and rapidly expanding knowledge are transforming what is possible for people living with Epidermolysis Bullosa.

Yet scientific excellence alone is no longer enough. Delivering meaningful patient benefit now depends on something different: our ability to work together. Across research, clinical care, patient advocacy, industry, regulators, policy makers and funders, remarkable expertise already exists. However, many activities remain fragmented, disconnected or duplicated. As the complexity of the EB landscape grows, so does the need for coordinated structures that enable collaboration, shared priorities and collective action. 
EB2027 will be created to address exactly this challenge. Rather than another scientific meeting, it is designed as a strategic working conference where stakeholders jointly develop the foundations of a stronger international EB ecosystem.

Building the future EB Ecosystem.

Together, we can.

Programme Overview

The EB2027 programme will be built around four interconnected pillars:

Organisers & Strategic Partners

Contact information

Dr. Anna Huber
Project Manager EB2027
anna.huber@debra-international.org

Zur Hauptnavigation